{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:16:50Z","timestamp":1783603010453,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study evaluates the influence of different dose rates on the radiation-related adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>The study involved 60 patients divided into three groups, each receiving different dose rates of the Flattening Filter-Free (FFF) 6MV IMRT technique: 20 patients at 600, 20 at 1000, and 20 at 1400. Acute adverse events were monitored weekly. The EORTC-translated QLQ-H&amp;N 35 questionnaire was used to assess health-related quality of life (QoL) according to established EORTC criteria during radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the initial phase of radiotherapy treatment, no significant differences were noted in the prevalence of conditions such as mucositis and weight loss among the treatment groups. However, weight loss showed a significant variation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028) at third week for the 600-dose rate group. From the fourth to fifth week, no notable differences emerged for mucositis and xerostomia among groups, while increase radiation dose rate was correlated with significant rise in dermatitis and dysphagia (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036, respectively). Similarly, from week five to six and from week six to seven, no significant differences were observed for mucositis. Yet significant increase in xerostomia and other conditions was evident with rising radiation dose rate. The evaluation of the QLQ-H&amp;N 35 for head and neck cancer patients revealed a numerical scale for symptom severity, from 1 (not at all) to 4 (very much). While differences in symptom intensity across dose rates were noted, they did not reach statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The dose rate appears to influence patient health outcomes, although it does not seem to affect the QoL during the period of radiotherapy course treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00375-6","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:41:08Z","timestamp":1783600868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective evaluation of dose rate effects on acute radiation toxicities and quality of life in head and neck cancer"],"prefix":"10.1186","volume":"38","author":[{"given":"Ahmed Adel","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahib M","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"ELemary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abouegylah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"375_CR1","first-page":"363","volume":"9","author":"CL Nigro","year":"2017","unstructured":"Nigro CL, Denaro N, Merlotti A, Merlano M. Head and neck cancer: improving outcomes with a multidisciplinary approach.Cancer Manag. Res. 2017;9:363\u201371.","journal-title":"Res"},{"key":"375_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","volume":"16","author":"JD Cramer","year":"2019","unstructured":"Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16:669\u201383.","journal-title":"Nat Rev Clin Oncol"},{"key":"375_CR3","first-page":"588","volume":"48","author":"K Pollaers","year":"2019","unstructured":"Pollaers K, Massingham I, Friedland PL, Farah CS. The economic burden of oral squamous cell carcinoma in Australia.J. Oral Pathol. Med. 2019;48:588\u201394.","journal-title":"Med"},{"key":"375_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon JP, le Ma\u00eetre A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head andneck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4\u201314.","journal-title":"Radiother Oncol"},{"issue":"2","key":"375_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ijrobp.2021.05.114","volume":"111","author":"L Van den Bosch","year":"2021","unstructured":"Van den Bosch L, van der Laan HP, van der Schaaf A, Oosting SF, Halmos GB, et al. Patient-reported toxicity and quality-of-life profiles in patients with head and neck cancer treated with definitive radiation therapy or chemo radiation. Int J Radiat Oncol Biol Phys. 2021;111(2):456\u201367.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"375_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5306\/wjco.v7.i2.220","volume":"7","author":"H Mason","year":"2016","unstructured":"Mason H, DeRubeis MB, Burke N, Shannon M, Karsies D, Wolf G, Eisbruch A, Worden F. Symptom management duringand after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: a review of the literature and areas for futureresearch. World J Clin Oncol. 2016;7:220\u20136.","journal-title":"World J Clin Oncol"},{"key":"375_CR7","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1007\/s00405-014-3462-z","volume":"272","author":"M Magnano","year":"2015","unstructured":"Magnano M, Mola P, Machetta G, Maffeis P, Forestiero I, Cavagna R, Artino E, Boffano P. The nutritional assessment ofhead and neck cancer patients. Eur Arch Oto-Rhino-Laryngol. 2015;272:3793\u20139.","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"375_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11864-017-0484-y","volume":"18","author":"SH Huang","year":"2017","unstructured":"Huang SH, O\u2019Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 2017;18:40.","journal-title":"Curr Treat Options Oncol"},{"key":"375_CR9","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.20640","volume":"15","author":"A Argiris","year":"2004","unstructured":"Argiris A, Li Y, Forastiere A. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinomaof the head and neck. Cancer. 2004;15:2222\u20139.","journal-title":"Cancer"},{"key":"375_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13148-017-0357-z","volume":"9","author":"C Furlan","year":"2017","unstructured":"Furlan C, Polesel J, Barzan L, Franchin G, Sulfaro S, Romeo S, Colizzi F, Rizzo A, Baggio V, Giacomarra V, et al. Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma. Clin Epigenetics. 2017;9:58.","journal-title":"Clin Epigenetics"},{"key":"375_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejmp.2017.05.071","volume":"38","author":"M Avanzo","year":"2017","unstructured":"Avanzo M, Stancanello J, El Naqa I. Beyond imaging: the promise of radiomics. Phys Med. 2017;38:122\u201339.","journal-title":"Phys Med"},{"key":"375_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fonc.2018.00035","volume":"8","author":"HS Gabry\u00b4s","year":"2018","unstructured":"Gabry\u00b4s HS, Buettner F, Sterzing F, Hauswald H, Bangert M. Design and selection of machine learning methods usingradiomics and dosiomics for normal tissue complication probability modeling of xerostomia. Front Oncol. 2018;8:35.","journal-title":"Front Oncol"},{"key":"375_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/cells8040333","volume":"8","author":"FH Tan","year":"2019","unstructured":"Tan FH, Bai Y, Saintigny P, Darido C. mTORsignalling in head and neck cancer: Heads up. Cells. 2019;8:333.","journal-title":"Cells"},{"key":"375_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Mark LB, Ten Haken RK, Yorke ED. Quantitative analysesof normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76:S3\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"375_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.radonc.2021.01.024","volume":"157","author":"L Van den Bosch","year":"2021","unstructured":"Van den Bosch L, van der Schaaf A, van der Laan HP, Hoebers FJP, Wijers OB, van den Hoek JGM, Moons KGM, Reitsma JB, Steenbakkers RJHM, Schuit E. Comprehensive toxicity risk profiling in radiation therapy for head and neckcancer: a new concept for individually optimised treatment. Radiother Oncol. 2021;157:147\u201354.","journal-title":"Radiother Oncol"},{"key":"375_CR16","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3389\/fonc.2020.01708","volume":"10","author":"I Desideri","year":"2020","unstructured":"Desideri I, Loi M, Francolini G, Becherini C, Livi L, Bonomo P. Application of radiomics for the prediction of radiationinducedtoxicity in the IMRT era: Current state-of-the-art. Front Oncol. 2020;10:1708.","journal-title":"Front Oncol"},{"key":"375_CR17","doi-asserted-by":"crossref","unstructured":"Mierzwa ML, Gharzai LA, Li P, Wilkie JR, Hawkins PJ, Aryal MP, Lee C, Rosen B, Lyden T, Blakely A et al. Early MRI blood volume changes in constrictor muscles correlate with postradiation dysphagia. Int. J. Radiat. Oncol. Biol. Phys.2021, in press.","DOI":"10.1016\/j.ijrobp.2020.12.018"},{"key":"375_CR18","first-page":"djv370","volume":"108","author":"SY Zafar","year":"2016","unstructured":"Zafar SY. Financial toxicity of cancer care: it\u2019s time to intervene. Gynecol Oncol. 2016;108:djv370.","journal-title":"Gynecol Oncol"},{"key":"375_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","volume":"10","author":"LG Gordon","year":"2017","unstructured":"Gordon LG, Merollini K, Lowe A, Chan R. A systematic review of financial toxicity among cancer survivors: we can\u2019t paythe co-pay. Patient. 2017;10:295\u2013309.","journal-title":"Patient"},{"key":"375_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/jamaoto.2018.3982","volume":"145","author":"ST Massa","year":"2019","unstructured":"Massa ST, Osazuwa-Peters N, Boakye EA, Walker RJ, Ward GM. Comparison of the financial burden of survivors of headand neck cancer with other cancer survivors. JAMA Otolaryngol Head Neck Surg. 2019;145:239\u201349.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"375_CR21","doi-asserted-by":"publisher","first-page":"105196","DOI":"10.1016\/j.oraloncology.2021.105196","volume":"115","author":"SJ Ma","year":"2021","unstructured":"Ma SJ, Iovoli AJ, Attwood K, Wooten KE, Arshad H, Gupta V, McSpadden RP, Kuriakose MA, Markiewicz MR, et al. Association of significant financial burden with survival for head and neck cancer patients treated with radiationtherapy. Oral Oncol. 2021;115:105196.","journal-title":"Oral Oncol"},{"issue":"8","key":"375_CR22","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/hed.23714","volume":"37","author":"AD Colevas","year":"2015","unstructured":"Colevas AD, Lira RR, Colevas EA, Lavori PW, Chan C, Shultz DB, Chang KW. Hearing evaluation of patients with head and neck cancer: comparison of common terminology criteria for adverse events, brock and chang adverse event criteria in patients receiving cisplatin. Head Neck. 2015;37(8):1102\u20137.","journal-title":"Head Neck"},{"issue":"4","key":"375_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOO.0000000000000641","volume":"28","author":"KL Crawford","year":"2020","unstructured":"Crawford KL, Stramiello JA, Orosco RK, Greene JJ. Advances in facial nerve management in the head and neck cancer patient. CurrOpinOtolaryngol Head Neck Surg. 2020;28(4):235\u201340. https:\/\/doi.org\/10.1097\/MOO.0000000000000641.","journal-title":"CurrOpinOtolaryngol Head Neck Surg"},{"key":"375_CR24","doi-asserted-by":"publisher","unstructured":"Jin JY, Gu A, Wang W, Oleinick NL, Machtay M, Spring Kong FM. Ultra-high dose rate effect on circulating immune cells: a potential mechanism for FLASH effect? RadiotherOncol. 2020; 149:55\u201362. https:\/\/doi.org\/10.1016\/j.radonc.2020.04.054","DOI":"10.1016\/j.radonc.2020.04.054"},{"issue":"12","key":"375_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11604-022-01303-z","volume":"40","author":"S Misaki","year":"2022","unstructured":"Misaki S, Murata S, Shimoji M, et al. Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor. Jpn J Radiol. 2022;40(12):1307\u201315. https:\/\/doi.org\/10.1007\/s11604-022-01303-z.","journal-title":"Jpn J Radiol"},{"key":"375_CR26","doi-asserted-by":"publisher","first-page":"245ra93","DOI":"10.1126\/scitranslmed.3008973","volume":"6","author":"V Favaudon","year":"2014","unstructured":"Favaudon V, Caplier L, Monceau V, et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 2014;6:245ra93. https:\/\/doi.org\/10.1126\/scitranslmed.3008973.","journal-title":"Sci Transl Med"},{"key":"375_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.radonc.2021.04.011","volume":"160","author":"HP van der Laan","year":"2021","unstructured":"van der Laan HP, Van den Bosch L, Schuit E, Steenbakkers RJHM, van der Schaaf A, Langendijk JA. Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer. Radiother Oncol. 2021;160:47\u201353. https:\/\/doi.org\/10.1016\/j.radonc.2021.04.011.","journal-title":"Radiother Oncol"},{"key":"375_CR28","doi-asserted-by":"publisher","first-page":"5566508","DOI":"10.1155\/2021\/5566508","volume":"2021","author":"R Carbonara","year":"2021","unstructured":"Carbonara R, Bonomo P, Di Rito A, Didonna V, Gregucci F, Ciliberti MP, et al. Investigation of radiation-induced toxicity in head and neck cancer patients through radiomics and machine learning: a systematic review. J Oncol. 2021;2021:5566508. https:\/\/doi.org\/10.1155\/2021\/5566508.","journal-title":"J Oncol"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00375-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:41:09Z","timestamp":1783600869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00375-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["375"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00375-6","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IRB of the ethical committee of the faculty of science, Suez Canal University in accordance with the declaration of Helsinki, NO: REC230\/2023 based on International Council for Laboratory Animal Science (ICLAS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent was obtained from all patients prior to participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}